Top Markets
#1 GALA GALA +32.47%
#2 Bitcoin Cash Bitcoin Cash +31.11%
#3 Fabric Protocol Fabric Protocol +30.87%
#4 Tutorial Tutorial +30.85%
#5 Binance-Peg Bitcoin Cash Binance-Peg Bitcoin Cash +30.64%
#6 Zora Zora +24.99%
#7 Talus Network Talus Network +24.40%
#8 Arowana Arowana +22.89%
#9 Useless Coin Useless Coin +22.84%
#10 aPriori aPriori +22.63%
Coin of the day
GALA GALA
Impostazioni
Lingua
ITALIANO
Valuta
USD
Tema
CellSeed Inc. CellSeed Inc.

CellSeed Inc.

7776
Classifica tra le azioni #24577
CellSeed Inc. focuses on pioneering regenerative therapies that utilize cell... CellSeed Inc. focuses on pioneering regenerative therapies that utilize cell sheet technology. The company is deeply involved in the research, development, and market introduction of advanced cell-sheet medicine products. Its innovations encompass epithelial cell sheets for repairing the esophagus, as well as both regenerated cartilage sheets and chondrocyte sheets aimed at addressing knee osteoarthritis. Beyond its therapeutic pipeline, CellSeed manufactures and distributes a range of specialized cell cultureware. This includes UpCell, a temperature-responsive cultureware vital for cell-sheet engineering; RepCell, another temperature-sensitive product designed for efficient cell collection; and HydroCell, distinguished by its low cell-binding properties. The firm also provides supporting equipment, such as ThermoPlate III, a heating element constructed from transparent glass, and cellZscope, an automated system for real-time cell monitoring. Additionally, CellSeed offers contract development and manufacturing services. Founded in 2001, the company's main operations are situated in Tokyo, Japan.
Prezzo delle azioni
$1.52
Capitalizzazione di mercato
$59.10M
Variazione (1 giorno)
-0.85%
Variazione (1 anno)
-51.30%
Paese
JP
Scambia CellSeed Inc. (7776)

Categoria

Healthcare
Utile per CellSeed Inc. (7776)
Utile nel 2026 TTM: 0
Secondo gli ultimi rapporti finanziari di CellSeed Inc., gli utili attuali della società sono 0. Nel 2026, la società ha registrato un utile di 0, uguale a agli utili del 2026, che erano di 0. Gli utili mostrati in questa pagina sono quelli prima degli interessi e delle imposte, ovvero EBIT.
Storico degli utili di CellSeed Inc. dal 2026 al 2026
Utile alla fine di ogni anno
Anno Utile Cambia
Non abbastanza dati per le date fornite.
Utile per aziende simili o concorrenti
Azienda Utile Differenza negli utili Il paese
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
$5.27B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
$1.95B -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
$1.61B -
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
$-3.09B -
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH